Clinical trial Recruiting at 1 site Interventional Ages 18 and up

CKD Awareness, Referrals, Education, and Support for Early-Stage CKD in Adults with Diabetes

Official title: CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD

Run by University of Illinois Chicago · NCT07210710 · Data updated 2026-11-12

This intervention tests whether education, motivational support, and social backing delivered virtually can help adults with diabetes and early CKD slow kidney decline and stay engaged with care.

More Diabetes trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of Illinois Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedNovember 15, 2025
Main results expectedDecember 30, 2026
Study endsJuly 31, 2027
Registry record updatedOctober 9, 2026
Trial IDNCT07210710 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with diabetes and eligible for CKD stage 3, who have had at least one prior UIHealth primary care visit and can speak English.

Probably not a fit

Patients who do not engage with virtual sessions or who have more advanced CKD or comorbidities not addressed by the program may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pilot interventional study evaluating a nurse-led, virtual education and support program called CARES for adults with diabetes and early-stage CKD. Participants receive a 1:1 virtual session about a week before a primary care visit and complete surveys by phone three times over three months. The study compares CARES to a control group receiving general diabetes information to see if the program improves motivation, self-efficacy, knowledge about CKD, and use of support services. Outcomes include feasibility, acceptability, and changes in patient-reported measures as well as potential effects on CKD-related care engagement. Enrollment targets adults 18+ with diabetes and CKD stage 3 who have had at least one prior visit at UIHealth primary care clinics and can speak English.

Why it matters

Potential benefit: If successful, CARES could help patients better manage CKD and stay connected to care, potentially slowing progression.

How similar studies have gone: Prior similar education and support interventions in CKD have shown potential to improve knowledge and engagement, but this exact virtual, nurse-led CARES approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults (18+)
* diabetes diagnosis (type 1 or 2)
* CKD Stage 3 diagnosis eligible
* \>1 prior visit at the UIHealth primary care clinics
* can speak English

Exclusion Criteria:

* CKD of congenital or pediatric onset
* history of kidney transplant
* cognitive impairment as documented in the medical record

Where it's running

  • University of Illinois Chicago Hospital
    Chicago, Illinois, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.